Lamivudine treatment in infantile fulminant hepatitis B
Journal
Pediatrics International
Journal Volume
52
Journal Issue
4
Pages
672-674
Date Issued
2010
Author(s)
SDGs
Other Subjects
alanine aminotransferase; aspartate aminotransferase; bilirubin; fresh frozen plasma; hepatitis B core antigen; hepatitis B surface antigen; hepatitis B vaccine; hepatitis B(e) antigen; immunoglobulin M antibody; lamivudine; virus DNA; vitamin K group; alanine aminotransferase blood level; article; aspartate aminotransferase blood level; bilirubin blood level; brain dysfunction; case report; consciousness disorder; decreased appetite; drowsiness; electroencephalogram; erythrocyte concentrate; exchange blood transfusion; fever; follow up; fulminant hepatic failure; genotype; hepatitis B; human; hyperammonemia; hyperreflexia; hypoglycemia; infant; infant disease; jaundice; liver failure; male; nuclear magnetic resonance imaging; priority journal; prothrombin time; somnolence; stupor; tandem mass spectrometry; urinalysis; virus replication; Antiviral Agents; Hepatitis B; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Liver Failure, Acute; Male; Reverse Transcriptase Inhibitors
Type
journal article